Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: AIDS Behav. 2022 Jan 21;26(7):2363–2375. doi: 10.1007/s10461-022-03575-y

Table 3:

Factors associated with preference for different PrEP modalities, bivariate and multivariable

Frequency of PrEP preferences Multinomial Logistic Regression
for PrEP preferencesa
Prefer daily
Oral pill
(n=62,21.0%)
Prefer LAI-
PrEP (n=131,
44.4%)
Prefer
other type
of PrEP
(subdermal
implant,
and rectal
microbicides
) (n=70,
23.7%)
Like them
all equally
(n=32,
10.9%)
P-value Prefer LAI-
PrEP
Prefer other
type of PrEP
(subdermal
implant, and
rectal
microbicides
Like them all
equally
Demographics
Site 0.06
 Abuja 12 (21.4) 19 (33.9) 17 (30.4) 8 (14.3) 0.58 (0.23-1.51) 1.65 (0.57-4.81) 3.11 (0.67-14.43)
 Delta 16 (18.4) 31 (35.6) 26 (29.9) 14 (16.1) 0.71 (0.30-1.69) 1.90 (0.70-5.11) 4.08 (0.97-17.2)
 Lagos 18 (22.0) 42 (51.2) 15 (18.3) 7 (8.5) 0.86 (0.38-1.96) 0.97 (0.35-2.73) 1.81 (0.40-8.31)
 Plateau 14 (20.9) 38 (56.7) 12 (17.9) 3 (4.5) Ref
Age 0.12
 18-24 years 17 (25.8) 27 (40.9) 18 (27.3) 4 (6.1) 0.69 (0.33-1.45) 1.22 (0.52-2.85) 0.54 (0.15-1.93)
 25-29 years 14 (16.5) 32 (37.7) 26 (30.6) 13 (15.3) 0.99 (0.47-2.13) 2.14 (0.93-4.94) 2.14 (0.79-5.81)
 30+ years 30 (21.7) 69 (50.0) 26 (18.8) 13 (9.4) Ref
Relationship Status 0.92
 Single 40 (21.9) 80 (43.7) 42 (22.9) 21 (11.5) 0.86 (0.46-1.62) 0.83 (0.41-1.67) 1.05 (0.43-2.57)
 Not Single 22 (19.6) 51 (45.5) 28 (25.0) 11 (9.8) Ref
Educational Attainment 0.04
 Senior Secondary School or lower 38 (27.3) 64 (46.0) 25 (18.0) 12 (8.6) Ref
 Some University/ University degree/higher 20 (14.5) 62 (44.9) 40 (29.0) 16 (11.6) 1.83 (0.97-3.51) 3.04 (1.46-6.4) * 2.53 (1.01-6.38) *
 Other 4 (22.2) 5 (27.8) 5 (27.8) 4 (22.2) 0.74 (0.19-2.94) 1.90 (0.47-7.77) 3.17 (0.69-14.6)
Sexual Orientation 0.25
 Gay/Homosexual 26 (23.6) 50 (45.5) 27 (24.6) 7 (6.4) 0.84 (0.45-1.56) 0.85 (0.42-1.70) 0.38 (0.14-1.00)
 Bisexual 35 (19.1) 80 (43.7) 43 (23.5) 25 (13.7) Ref
Religious Affiliation 0.006
 Christian 37 (19.7) 80 (42.6) 50 (26.6) 21 (11.2) Ref
 Muslim 23 (26.7) 46 (53.5) 11 (12.8) 6 (7.0) 0.93 (0.49-1.74) 0.35 (0.15-0.82) ** 0.46 (0.16-1.31)
 Other 2 (10.0) 5 (25.0) 8 (40.0) 5 (25.0) 1.16 (0.21-6.24) 2.96 (0.59-14.8) 4.41 (0.79-24.7)
Social Marginalization 0.21
Monthly income (in Naira)
 0-10,000 21 (26.6) 36 (45.6) 16 (20.3) 6 (7.6) Ref
 10,000-30,000 14 (17.5) 35 (43.8) 21 (26.3) 10 (12.5) 1.46 (0.64-3.31) 1.97 (0.77-5.03) 2.50 (0.74-8.45)
 30,000-50,000 18 (30.0) 24 (40.0) 14 (23.3) 4 (6.7) 0.78 (0.35-1.76) 1.02 (0.39-2.65) 0.78 (0.19-3.20)
 50,000-100,000 5 (14.7) 15 (44.1) 11 (32.4) 3 (8.8) 2.77 (0.83-9.25) 1.97 (0.48-8.17) 7.00 (1.56-31.5) *
 100,000+ 4 (10.8) 19 (51.4) 6 (16.2) 8 (21.6) 1.75 (0.56-5.51) 2.89 (0.84-9.99) 2.10 (0.39-11.43)
Employment Status 0.33
 Employed 51 (21.8) 104 (44.4) 51 (21.8) 28 (12.0) 0.83 (0.38-1.81) 0.56 (0.25-1.34) 1.51 (0.44-5.19)
 Unemployed 11 (18.0) 27 (44.3) 19 (31.2) 4 (6.6) Ref
Financial Hardship 0.004
 High 43 (25.0) 81 (47.1) 37 (21.5) 11 (6.4) Ref
 Low 18 (15.0) 48 (40.0) 33 (27.5) 21 (17.5) 1.42 (0.74-2.73) 2.13 (1.03-4.4) * 4.56 (1.83-11.4) *
Sexual Health
Any history of STIs 0.43
 Yes 22 (18.5) 52 (43.7) 28 (23.5) 17 (14.3) 1.21 (0.65-2.27) 1.21 (0.60-2.46) 2.06 (0.87-4.91)
 No 40 (22.9) 78 (44.6) 42 (24.0) 15 (8.6) Ref
STIs in the past year 0.19
 Yes 15 (17.7) 39 (45.9) 17 (20.0) 14 (16.5) 1.36 (0.68-2.71) 1.02 (0.46-2.28) 2.44 (0.98-6.05)
 No 47 (22.7) 90 (43.5) 52 (25.1) 18 (8.7) Ref
# of Receptive Anal sex acts in last 30 days 0.99
 0 29 (20.9) 63 (45.3) 30 (21.6) 17 (12.2) Ref
 1 8 (19.1) 19 (45.2) 11 (26.2) 4 (9.5) 1.09 (0.43-2.79) 1.33 (0.47-3.78) 0.85 (0.22-3.26)
 2-3 13 (20.3) 29 (45.3) 17 (26.6) 5 (7.8) 1.03 (0.47-2.26) 1.26 (0.52-3.06) 0.66 (0.20-2.16)
 4+ 12 (24.5) 20 (40.8) 12 (24.5) 5 (10.2) 0.77 (0.33-1.78) 0.97 (0.37-2.50) 0.71 (0.21-2.37)
# of Insertive Anal sex acts in last 30 days 0.68
 0 22 (21.6) 45 (44.1) 22 (21.6) 13 (12.8) Ref
 1 6 (15.8) 16 (42.1) 12 (31.6) 4 (10.5) 1.30 (0.45-3.79) 2.00 (0.64-6.28) 1.13 (0.27-4.76)
 2-3 12 (16.7) 36 (50.0) 19 (26.4) 5 (6.9) 1.47 (0.64-3.36) 1.58 (0.62-4.03) 0.71 (0.20-2.46)
 4+ 22 (27.5) 32 (40.0) 17 (21.3) 9 (11.3) 0.71 (0.34-1.50) 0.77 (0.33-1.84) 0.69 (0.25-1.95)
Consistent condom use for receptive sex acts in the last 3 months 0.67
 Yes 42 (20.9) 86 (42.8) 49 (24.4) 24 (11.9) 0.91 (0.48-1.73) 1.23 (0.58-2.60) 1.43 (0.55-3.74)
 No 20 (21.7) 45 (48.9) 19 (20.7) 8 (8.7) Ref
Consistent condom use for insertive sex acts in the last 3 months 0.62
 Yes 39 (20.7) 79 (42.0) 49 (26.1) 21 (11.2) 0.95 (0.51-1.78) 1.45 (0.70-3.00) 1.13 (0.46-2.75)
 No 23 (22.3) 49 (47.6) 20 (19.4) 11 (10.7) Ref
Geosocial Networking app usage in previous 3 months 0.40
 Yes 31 (21.1) 65 (44.2) 31 (21.1) 20 (13.6) 0.99 (0.54-1.80) 0.80 (0.40-1.58) 1.67 (0.70-4.00)
 No 31 (21.0) 66 (44.6) 39 (26.4) 12 (8.1) Ref
Exchange sex in previous 3 months 0.71
 Yes 25 (22.9) 49 (44.9) 26 (23.9) 9 (8.3) 0.88 (0.48-1.64) 0.88 (0.43-1.76) 0.58 (0.23-1.46)
 No 37 (19.9) 82 (44.1) 44 (23.7) 23 (12.4) Ref
Healthcare Access
Primary care Provider 0.04
 Yes 23 (18.1) 65 (51.2) 22 (17.3) 17 (13.4) 1.67 (0.90-3.10) 0.78 (0.38-1.60) 1.92 (0.81-4.56)
 No 39 (23.2) 66 (39.3) 48 (28.6) 15 (8.9) Ref
Health Insurance 0.71
 Yes 9 (20.0) 23 (51.1) 8 (17.8) 5 (11.1) 1.24 (0.54-2.87) 0.75 (0.27-2.07) 1.07 (0.33-3.51)
 No 52 (21.0) 107 (43.2) 62 (25.0) 27 (10.9) Ref
Unable to assess medical care due to cost in last year 0.57
 Yes 22 (17.3) 58 (45.7) 33 (26.0) 14 (11.0) 1.44 (0.77-2.70) 1.62 (0.81-3.27) 1.41 (0.59-3.38)
 No 40 (23.8) 73 (43.5) 37 (22.0) 18 (10.7) Ref
PrEP Indicators
Awareness of PrEP 0.53
 Yes 24 (17.9) 63 (47.0) 34 (25.4) 13 (9.7) 1.45 (0.78-2.69) 1.54 (0.77-3.10) 1.06 (0.44-2.52)
 No 37 (23.6) 67 (42.7) 34 (21.7) 19 (12.1) Ref
History of oral PrEP Use 0.59
 Yes 12 (27.3) 20 (45.5) 9 (20.5) 3 (6.8) 0.75 (0.34-1.65) 0.63 (0.24-1.60) 0.43 (0.11-1.66)
 No 50 (20.0) 111 (44.4) 60 (24.0) 29 (11.6) Ref
a

Multinomial regression, dependent variable = preferring LAI-PrEP, other type of PrEP (subdermal implant, and rectal microbicides), or liking them all equally, compared to preferring a daily oral pill

*

p<0.05

**

p<0.01